These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 12151478)
21. Glycoprotein inhibitors and fibrinolysis in myocardial infarction. Ring BL JAMA; 2000 Dec; 284(24):3124-5. PubMed ID: 11135766 [No Abstract] [Full Text] [Related]
22. Future trials of antiplatelet agents in cardiac ischemia. Throckmorton DC N Engl J Med; 2001 Jun; 344(25):1937-9. PubMed ID: 11419432 [No Abstract] [Full Text] [Related]
23. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
24. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role? Mukherjee D; Roffi M J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343 [No Abstract] [Full Text] [Related]
25. The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? Brener SJ J Am Coll Cardiol; 2009 May; 53(18):1674-6. PubMed ID: 19406343 [No Abstract] [Full Text] [Related]
26. No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction. Chaitman BR; Lim MJ J Am Coll Cardiol; 2004 Jul; 44(2):313-5. PubMed ID: 15261924 [No Abstract] [Full Text] [Related]
27. Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention. Kereiakes DJ J Invasive Cardiol; 2009 Mar; 21(3):110-3. PubMed ID: 19258641 [No Abstract] [Full Text] [Related]